SCHEMBL14221977

SCHEMBL14221977

CCc1cc(C[C@@H](CBr)[C@@H](CBr)Cc2ccc(OC)c(OC)c2)ccc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.51
ALOX15 P16050 2/20 0.50
PKM P14618 1/20 0.50
CA2 P00918 1/20 0.46
ALOX12 P18054 1/20 0.44
MMP1 P03956 1/20 0.43
CYP3A4 P08684 1/20 0.43
ATM Q13315 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 2/20 0.41
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
STAT3 P40763 1/20 0.40
POLB P06746 1/20 0.40
CYP19A1 P11511 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4245548 0.89 LDHA (0.57) LDHAALOX15CA2ALOX12MMP1
SCHEMBL14221975 0.85 CYP3A4 (0.61) LDHAALOX15PKMCA2ALOX12
SCHEMBL14239569 0.83 ALOX15 (0.63) LDHAALOX15PKMCA2ALOX12
SCHEMBL14221347 0.79 LDHA (0.51) LDHAALOX15PKMCA2ALOX12
SCHEMBL15070935 0.78 ALOX15 (0.50) LDHAALOX15PKMALOX12PPARD
SCHEMBL11950523 0.75 CA2 (0.48) ALOX15PKMCA2SMN1; SMN2LMNA
SCHEMBL14221354 0.74 CYP3A4 (0.58) LDHAALOX15PKMCA2ALOX12
SCHEMBL15616350 0.74 ALOX15 (0.63) LDHAALOX15CA2ALOX12ATM
SCHEMBL20286678 0.73 CA2 (0.63) ALOX15PKMCA2ATMALDH1A1
SCHEMBL4072201 0.73 CYP3A4 (0.75) LDHAALOX15CA2ALOX12MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008042921-A2 TETRA-O-SUBSTITUTED BUTANE-BRIDGE MODIFIED NDGA DERIVATIVES, THEIR SYNTHESIS AND PHARMACEUTICAL USE ERIMOS PHARMACEUTICALS LLC (US) 2008-04-10 WO disclosed